» Articles » PMID: 35441607

Pediatric Traumatic Brain Injury: a New Relation Between Outcome and Neutrophil-to-lymphocite Ratio

Abstract

Leading causes of death in industrialized countries are traumatic injuries and acquired disability, and entry to the emergency department in childhood. TBI (traumatic brain injury) may involve the onset of both primary lesions and a complex immune response (sterile immune reaction to brain injury), which, in addition to neuro-protective effects, can mediate secondary neurological injury. The neutrophil-to-lymphocyte ratio (NLR), as a circulating inflammatory marker, has been related to outcomes in adult patients with non-neurologic diseases (such as gut tumours) or neurologic diseases (such as stroke or brain tumours), and to the prognosis of traumatic brain injury in adolescents and adults. However, the potential role of NLR in predicting outcomes in paediatric head trauma is not clearly defined. The aim of this retrospective observational study is to evaluate the association between clinical features predictive of intracranial and extracranial lesions in TBI and NLR and to establish whether an elevation of NLR is indirectly associated with adverse outcomes in pediatric patients with TBI. We analysed a sample of 219 pediatric patients, between 2-18 years old, after a TBI, and evaluated if differences in NLR were associated with neurological signs or positive CT in pediatric patients. We then compared the NLR values ​​between healthy subjects and patients with TBI.

Citing Articles

Utility of systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio as a predictive biomarker in pediatric traumatic brain injury.

Parenrengi M, Suryaningtyas W, Dariansyah A, Utomo B, Taryana G, Kusumo C Surg Neurol Int. 2025; 15():456.

PMID: 39777169 PMC: 11704429. DOI: 10.25259/SNI_900_2024.


Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke.

Duan M, Xu Y, Li Y, Feng H, Chen Y J Neuroinflammation. 2024; 21(1):102.

PMID: 38637850 PMC: 11025216. DOI: 10.1186/s12974-024-03101-y.


Acute Fluid Biomarkers for Diagnosis and Prognosis in Children with Mild Traumatic Brain Injury: A Systematic Review.

Malhotra A, Ide K, Salaheen Z, Mahood Q, Cunningham J, Hutchison J Mol Diagn Ther. 2023; 28(2):169-187.

PMID: 38133736 DOI: 10.1007/s40291-023-00685-8.


Neutrophil to Lymphocyte Ratio as a Predictor of Postoperative Outcomes in Traumatic Brain Injury: A Systematic Review and Meta-Analysis.

Nguyen A, Nguyen A, Hsu T, Lew H, Gupta N, Nguyen B Diseases. 2023; 11(1).

PMID: 36975600 PMC: 10047119. DOI: 10.3390/diseases11010051.


High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth-Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen.

Kast R Cancers (Basel). 2022; 14(19).

PMID: 36230888 PMC: 9564173. DOI: 10.3390/cancers14194965.

References
1.
Orsini A, Foiadelli T, Costagliola G, Michev A, Consolini R, Vinci F . The role of inflammatory mediators in epilepsy: Focus on developmental and epileptic encephalopathies and therapeutic implications. Epilepsy Res. 2021; 172:106588. DOI: 10.1016/j.eplepsyres.2021.106588. View

2.
Elsawaf Y, Anetsberger S, Luzzi S, Elbabaa S . Early Decompressive Craniectomy as Management for Severe Traumatic Brain Injury in the Pediatric Population: A Comprehensive Literature Review. World Neurosurg. 2020; 138:9-18. DOI: 10.1016/j.wneu.2020.02.065. View

3.
McKee C, Lukens J . Emerging Roles for the Immune System in Traumatic Brain Injury. Front Immunol. 2016; 7:556. PMC: 5137185. DOI: 10.3389/fimmu.2016.00556. View

4.
Luzzi S, Lucifero A, Brambilla I, Semeria Mantelli S, Mosconi M, Foiadelli T . Targeting the medulloblastoma: a molecular-based approach. Acta Biomed. 2020; 91(7-S):79-100. PMC: 7975825. DOI: 10.23750/abm.v91i7-S.9958. View

5.
Savioli G, Ceresa I, Macedonio S, Gerosa S, Belliato M, Iotti G . Trauma Coagulopathy and Its Outcomes. Medicina (Kaunas). 2020; 56(4). PMC: 7230692. DOI: 10.3390/medicina56040205. View